<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04548375</url>
  </required_header>
  <id_info>
    <org_study_id>PainReg</org_study_id>
    <nct_id>NCT04548375</nct_id>
  </id_info>
  <brief_title>Multicenter Outcome Registry of AnaLgesic Effect of SCS(MORALES) Registry Protocol</brief_title>
  <official_title>Multicenter Outcome Registry of AnaLgesic Effect of SCS(MORALES) Registry Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardio Surgical Partners</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cardio Surgical Partners</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to provide information to help the physician community decide the most&#xD;
      effective type of device/therapy that would work for their patients, based off of the&#xD;
      etiology of pain, the location of the pain for sustained pain relief.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This registry will enroll patients that qualify for an SCS implant, for approved pain areas,&#xD;
      as defined by medicare guidelines, and follow these patients for up to 12 months for denovo&#xD;
      implants. For patients who have lost their pain relief over time, with a prior implanted&#xD;
      device, this registry will follow a change out to another vendor/therapy, and follow those&#xD;
      patients for up to 12 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2020</start_date>
  <completion_date type="Anticipated">November 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Change in pain relief</measure>
    <time_frame>12 months</time_frame>
    <description>Percent of patient who show a change in Pain Scale (PIPS) &gt;50% at the end of follow up period of 12 months</description>
  </primary_outcome>
  <other_outcome>
    <measure>Sustained change of pain over the follow up period</measure>
    <time_frame>12 months</time_frame>
    <description>Sustained Percentage change in Pain Scale (PIPS)&gt;50% for the 12 month follow up period.</description>
  </other_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>SCS</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SCS</intervention_name>
    <description>Conventional SCS implants approved through all payors(government and private) for FDA approved indications</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All SCS implants&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  FDA approved indications for SCS implants, for commercial and government(medicare,&#xD;
             medi-cal etc) approved payors&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 26, 2020</study_first_submitted>
  <study_first_submitted_qc>September 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2020</study_first_posted>
  <last_update_submitted>October 31, 2020</last_update_submitted>
  <last_update_submitted_qc>October 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

